Related Experiment Videos
Optic nerve damage in mice with a targeted type I collagen mutation
Fumihiko Mabuchi1, James D Lindsey, Makoto Aihara
1Hamilton Glaucoma Center, University of California San Diego, La Jolla 92093-0946, USA.
Investigative Ophthalmology & Visual Science
|May 27, 2004
Summary
Transgenic mice with elevated intraocular pressure (IOP) showed significant optic nerve axon loss over time. These findings support their use as a model for studying glaucoma and collagen's role in optic nerve damage.
Area of Science:
- Ophthalmology
- Genetics
- Neuroscience
Background:
- Transgenic Col1a1(r/r) mice exhibit a gradual increase in intraocular pressure (IOP) with open angles.
- This genetic modification provides a model for studying conditions associated with elevated IOP.
Purpose of the Study:
- To investigate and quantify optic nerve axonal loss in transgenic Col1a1(r/r) mice over time.
- To establish a correlation between sustained elevated IOP and neurodegeneration in the optic nerve.
Main Methods:
- Intraocular pressure (IOP) was measured in transgenic Col1a1(r/r) and control wild-type mice at multiple age points (7-54 weeks) using a microneedle method.
- Optic nerves were analyzed via electron microscopy at 24 and 54 weeks to determine axonal density and total axonal number.
- Axonal counts were performed on masked, systematically collected cross-sections posterior to the globe.
Main Results:
- Transgenic mice demonstrated significantly higher IOP compared to controls from 16 weeks onwards.
- A significant reduction in mean axonal density and total axonal number was observed in transgenic mice at 54 weeks compared to controls and to younger transgenic mice.
- Mean axonal loss in transgenic mice between 24 and 54 weeks was approximately 28.7%.
Conclusions:
- Transgenic Col1a1(r/r) mice exhibit sustained elevated IOP and progressive optic nerve axon loss.
- These mice represent a valuable model for primary open-angle glaucoma research.
- The model facilitates the study of the relationship between collagen type I metabolism and optic nerve damage.